Neurocognitive improvement through plant food bioactives: A particular approach to Alzheimer's disease by Martins, Natália & Ferreira, Isabel C.F.R.
Chapter 11
Neurocognitive Improvement Through
Plant Food Bioactives: A Particular
Approach to Alzheimer’s Disease
Natália Martins and Isabel C.F.R. Ferreira
1 Introduction
Alzheimer’s disease (AD) is currently one of the most prevalent neurodegenerative
disorders, directly related to increasing rates of morbidity and autonomy impair-
ment between worldwide citizens. Social and demographical changes are direct
contributors; notwithstanding, modern lifestyle, oxidative stress and its related
diseases, and, consequently, premature aging are also important triggering factors
(Sun et al. 2008; Ngo and Li 2013).
Numerous drugs have been developed mainly to act as symptomatic agents,
despite the serious side effects and increasing evidences of lack of effectiveness.
Most of them were derived from plant-mimetic synthesis, but tenuous differences
on their chemical structure and also the occurrence of synergisms in the pool of the
whole plant phytochemicals are sufﬁcient to provide considerable influences on the
ﬁnal biological potential (Ngo and Li 2013; Katalini et al. 2014; Ahmed et al.
2015). The use of medicinal plants, mainly through botanical preparations, is a
millenary practice, which has been effectively used for a multitude of health con-
ditions (Vanaclocha and Cañigueral 2003; Murray 2004; Murray and Pizzorno
2012). The interest for natural matrices is still increasing, not only to conﬁrm its
bioactive potential, but also to deepen knowledge on the modes of action, meta-
bolism, bioavailability, bioefﬁcacy, and active concentrations, aiming to develop
upcoming and safer alternatives to the current ones. Among them, plant phyto-
chemicals have shown to have promissory neurocognitive properties. In this sense,
the present chapter aims to provide systematic information about the use of
plant-food-derived bioactive molecules with evident in vitro and in vivo neuro-
protective and neuroregenerative effects.
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2 Alzheimer’s Disease: Current Perspective
Human life cycle is a complex process, and numerous aspects still remain a mys-
tery. Apart from the birth, growth, and maturation phases, the aging process is also
an important focus among medical community and scientists. Memory decline and
cognitive functions comprise the most evident signals of brain changes and activity
impairment (Alza et al. 2014).
In the last decades, an exponential increase of brain-related diseases, namely
neurodegenerative diseases, has been observed. Taking into account social
and demographic changes, in which older people assume the leadership, it is nor-
mally conceived that age-related diseases tends to increase progressively.
Notwithstanding, and disturbingly, a double prevalence every 20 years has been
counted, increasing nearly to 115 million by 2050 (Vauzour 2014). Among the
neurodegenerative diseases, AD and Parkinson’s (PD) diseases, also dementia,
comprise the most representative and alarming causes of morbidity and autonomy
impairment among worldwide population (Vauzour 2014; Ahmed et al. 2015; Sun
et al. 2015). Genetic and human lifestyle has been pointed as the most pronounced
triggering factors to the development of those complex medical conditions (Sun
et al. 2008; Vauzour 2014; Ahmed et al. 2015). One of the ﬁrst features in patients
with AD is the presence of brain lesions, commonly known as senile plaques:
deposits of b-amyloid (Ab) protein between neurons (Kumar and Nisha 2014;
Adewusi and Steenkamp 2015). Being a product from sequential proteolytic
cleavage, Ab is abnormally accumulated in older individuals due to a clearance
impairment and/or its overproduction. In particular, to Ab overproduction, genetic
changes/mutations, namely from amyloid precursor protein (APP), are underlying,
being related to early AD manifestation (Yoo and Park 2012). High doses of Ab are
highly toxic, due to its ability of self-aggregation, forming, respectively, ﬁbrillary or
monomeric and then oligomeric forms. Particularly, Ab aggregated as oligomers is
highly harmful once acting as oxidative stress enhancer. Thus, and in association
with free radical overproduction, Ab oligomeric forms largely determine the
magnitude of cognitive damages, leading to synaptic dysfunctions, inflammation,
and, consequently, organic dysfunctions (Yoo and Park 2012; Kumar and Nisha
2014). Ab also induces neuronal death and activates downstream c-Jun N-terminal
kinase signal and N-methyl-D-aspartate-type glutamate receptor (NMDAR), which
leads to synaptic loss and improves neuronal dysfunction (Yoo and Park 2012).
Several studies indicate that the main components present in amyloid plaques of
AD individuals range from 40 and 42 amino acid sequences (Patil et al. 2010;
Kumar and Nisha 2014). Acetylcholine shortage is also a triggering factor for
neuronal decline and AD progression (Yoo and Park 2012). Despite all the phar-
maceutical advances, acetylcholinesterase (AChE) inhibitors still remain the most
popular prescribed drugs for symptomatic intervention, such as donepezil, galan-
tamine, rivastigmine, and tacrine. Memantine is also used but acts as N-methyl-D-
aspartic acid modulator (Ngo and Li 2013). Notwithstanding, those drugs possess
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numerous side effects and evidence a weak ability to block and even to reverse AD,
acting only on clinical symptoms, but not on causal factors or prevention.
Botanical preparations are a complex pool of phytochemicals, being their
ethnopharmacological potential mainly conferred by secondary metabolites
(Spencer et al. 2012). Particularly to AD, a multitude of studies have shown that
they act as prominent brain health improvers, being useful not only to prevent but
also to block and even avert neurological dysfunctions (Marco and Carreiras 2006;
Essa et al. 2012; Smid et al. 2012; Spencer et al. 2012; Konrath et al. 2013; Ahmed
et al. 2015). Furthermore, it is convenient to highlight that the majority of chemical
drugs are plant-derived mimetic; notwithstanding, in the whole plant, different
proportions of phytochemicals, their synergisms, antagonisms, and polyvalent
reactions improve the bioactive potential and also block some harmful substances.
Apart from those aspects, a correct and active lifestyle, which includes physical
and intellectual activity, and balanced diet are also well-established aspects that
provide important beneﬁts to preserve, improve, and even block memory and
cognition impairment (van Praag 2009; Murray and Pizzorno 2012). Regarding
dietary aspects, not only correct food choices, but also nutritional supplementation
confers prominent influences. Functional foods and nutraceuticals have the ability
to act as bioactives by simply enriching daily diet (Murray and Pizzorno 2005,
2012). Overall, the use of plant-derived preparations, as part of a healthy lifestyle,
might have a great impact on life expectancy and health improvement.
3 Plant-Food-Based Formulations: An Integrative
Approach
Natural matrices are an extremely rich source of bioactive molecules. Through
photosynthesis, numerous organic compounds mainly derived from primary (lipids,
proteins, carbohydrates, and chlorophyll) and secondary (such as, terpenes, steroids,
alkaloids, and phenolic compounds) metabolites are daily produced by higher
plants (Nelson and Cox 2000). They possess crucial biological functions, most of
them related to their proper survival, optimum growth, nutrition, and protection
against invaders (Nelson and Cox 2000). Notwithstanding, increasing evidences
conﬁrm phytochemical, human health beneﬁts, when integrated as part of daily
routine (Cowan 1999; Fernandez-Panchon et al. 2008; Kaushik et al. 2010;
Goodman et al. 2011).
Several plant-derived preparations can be used according to the ﬁnal biological
potential and/or selected phytochemical(s). For example, berries (such as blueberry,
cranberry, bilberry, grapes, barberry, and strawberry) have been related to antiaging
beneﬁts, mainly due to their richness in phenolic compounds, including antho-
cyanins (Larrosa et al. 2010; Tulipani et al. 2011; Hoggard et al. 2013; Norberto
et al. 2013; McKay et al. 2015). They can be directly consumed as fresh fruits,
or even through infusions/decoctions, capsules, drops, and extracts, among others.
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Despite the health-improving effects, the abundance of bioactive compounds in
those matrices is doubtless different, and therefore, the ﬁnal phytopharmacological
potential will considerably vary. Apart from this aspect, the bioavailability and
related bioefﬁcacy of plant phytochemical preparations will also differ (Holst and
Williamson 2008; Rein et al. 2013; Velderrain-Rodríguez et al. 2014). It means that
despite the promissory bioactive properties of numerous natural products, it is
important to select the most adequate extraction solvent, binomial time/temperature,
or type of formulation/preparation, according to each speciﬁc ﬁnality. All of the
stated premises assume that those products are correctly controlled in order to
possess the higher abundance in bioactive constituents.
Regarding plant-derived phytochemicals with documented in vitro and in vivo
neuroprotective (Tables 1, 2, 3, 4, 5, 6 and 7) and neuroregenerative (Figs. 1, 2, 3, 4
and 5) effects, methanol (MeOH), water (H2O), ethanol (EtOH), and mixtures of the
previous (MeOH: H2O; EtOH: H2O) extraction solvents, in different proportions,
are amongst to the most commonly used extraction solvents. Dichloromethane
(DCM), ethyl acetate (EtOAc), n-butanol, chloroform, and DCM: MeOH have also
been sporadically used, mainly for alkaloid, terpene, and saponin extraction.
It is convenient to highlight that the use of solvent mixtures, such as MeOH:
H2O, has been increasingly adopted. In fact, recent studies show that speciﬁc
proportions of solvent mixtures improve the efﬁciency of extraction and conse-
quently the richness on bioactive molecules in the ﬁnal extract.
4 Plant Food Bioactive Molecules with Neuroprotective
Activity
4.1 Bioactive Compounds with In Vitro Neuroprotective
Activity
4.1.1 Commercial Molecules
Tables 1 and 2 show the major groups of compounds from commercial origin with
reported in vitro neuroprotective effects.
Among phenolic compounds (Table 1), flavan-3-ols, flavones, flavonols, iso-
flavones, lignans, phenolic acids, and stilbenes comprise the most common classes.
Quercetin (a flavonol), followed by myricetin (a flavonol) and kaempferol (a fla-
vonol), and then apigenin (flavone), baicalein (flavone), catechin (flavan-3-ols), and
EGCG (flavan-3-ols) are the most studied phenolic compounds. In particular,
quercetin has shown several neuroprotective effects, being its ability to reduce
and/or to prevent reactive oxygen species (ROS) overproduction amongst to the
most prominent; its active concentrations varied signiﬁcantly according to the
model used, but interestingly, as described by Vepsäläinen et al. (2013), at 0.5, 2.5,
and 10 µM a, pronounced reduction in ROS overproduction was observed in
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Table 1 Phenolic compounds (from commercial origin) with reported in vitro neuroprotective
effects
Bioactive
molecule
Experimental models Active
concentration
Reference
Flavan-3-ols
Catechin Mouse cortical neuron cultures 30 µMa Choi et al.
(2014)
Unilamellar vesicles, Ab42-induced
liposome permeabilization
50 µM Gauci et al.
(2011)
EGCG Unilamellar vesicles, Ab42-induced
liposome permeabilization
50 µM Gauci et al.
(2011)
Mouse cortical neuron cultures 30 µMa Choi et al.
(2014)
Epicatechin Mouse cortical neuron cultures 30 µMa Choi et al.
(2014)
Flavones
Apigenin Unilamellar vesicles, Ab42-induced
liposome permeabilization
50 µM Gauci et al.
(2011)
Mouse cortical neuron cultures 30 µMa Choi et al.
(2014)
Baicalein Unilamellar vesicles, Ab42-induced
liposome permeabilization
50 µM Gauci et al.
(2011)
Mouse cortical neuron cultures 30 µMa Choi et al.
(2014)
Luteolin Mouse cortical neuron cultures 30 µMa Choi et al.
(2014)
Morin Unilamellar vesicles, Ab42-induced
liposome permeabilization
50 µM Gauci et al.
(2011)
Scutellarein Unilamellar vesicles, Ab42-induced
liposome permeabilization
50 µM Gauci et al.
(2011)
Flavonols
Fisetin Unilamellar vesicles, Ab42-induced
liposome permeabilization
50 µM Gauci et al.
(2011)
Kaempferol PC12 cells 3–30 µM Roth et al.
(1999)
Human T47D breast cancer cells 3–30 µM Roth et al.
(1999)
Mouse cortical neuron cultures 30 µMa Choi et al.
(2014)
Myricetin Th-T assay 1.95 µMb Xie et al.
(2014)
Human SH-SY5Y neuroblastoma cells,
menadione-induced ROS production
0.5, 2, 5, 10,
20 µM
Vepsäläinen
et al. (2013)
Unilamellar vesicles, Ab42-induced
liposome permeabilization
50 µM Gauci et al.
(2011)
(continued)
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Table 1 (continued)
Bioactive
molecule
Experimental models Active
concentration
Reference
Mouse cortical neuron cultures 30 µMa Choi et al.
(2014)
Quercetin Mouse cortical neuron cultures 30 µMa Choi et al.
(2014)
Primary cultures of astrocytes and
microglial cells
8 µMb,c Elmann et al.
(2013)
Primary cultures of astrocytes 10 µM Elmann et al.
(2014)
Unilamellar vesicles, Ab42-induced
liposome permeabilization
50 µM Gauci et al.
(2011)
Human SH-SY5Y neuroblastoma cells,
menadione-induced ROS production
0.5, 2, 5,
10 µM
Vepsäläinen
et al. (2013)
Bovine serum albumin, D-
ribose-induced AGE formation
600 lMb Ferchichi
et al. (2012)
Isoflavones
Genistein Unilamellar vesicles, Ab42-induced
liposome permeabilization
50 µM Gauci et al.
(2011)
Lignans
NDGA Unilamellar vesicles, Ab42-induced
liposome permeabilization
50 µM Gauci et al.
(2011)
Phenolic acids
3,5-di-O-
Caffeoylquinic
acid
Human neuroblastoma clonal SH-SY5Y
Ab1–42-treated cells
20 µM Han et al.
(2010)
Caffeic acid Th-T assay 118 µMb Kurisu et al.
(2013)
Chlorogenic
acid
Bovine serum albumin, D-
ribose-induced AGE formation
2000 lMb Ferchichi
et al. (2012)
Ferulic acid Mutant human APP-overexpressing
murine neuron-like cells
1.563–
12.5 µM
Mori et al.
(2013)
p-Coumaric
acid
PC12 cells, Ab25−35-induced toxicity 5, 25, 50 µM Yoon et al.
(2014)
Rosmarinic
acid
PC12 cells, Ab25-35-induced
neurotoxicity
23.6 µMd Na et al.
(2010)
Unilamellar vesicles, Ab42-induced
liposome permeabilization
50 µM Gauci et al.
(2011)
Stilbenes
Resveratrol Unilamellar vesicles, Ab42-induced
liposome permeabilization
50 µM Gauci et al.
(2011)
aTested concentration to measure the percentage of LDH release after 20 lM Ab25–35 exposure;
bIC50 values;
cvaried according to the used assay; dED50 value
EGCG Epigallocatechin gallate; NDGA nordihydroguaiaretic acid; ROS reactive oxygen species;
Th-T assay Thioflavin-T assay; AGEs advanced glycation end-products
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Table 2 Non-phenolic compounds (from commercial origin) with reported in vitro neuroprotec-
tive effects
Bioactive molecule Experimental models Active
concentration
Reference
Glycosides
Salidroside SH-SY5Y human
neuroblastoma cells,
b-amyloid-induced oxidative
stress
10, 50,
100 µM
Zhang
et al.
(2010)
Iridoid glycosides
Geniposide N2a cell
formaldehyde-exposed
200 µM Chen et al.
(2014)
Phenylethanoids
Acteoside-tetramethylether Th-T assay >200 µMa Kurisu
et al.
(2013)
Hydroxytyrosol 96 µMa
Oraposide-tetramethylether >200 µMa
Quinones
1,4-Benzoquinone Insulin as amyloid model 50 µM Gong et al.
(2014)1,4-Naphthoquinone
9,10-Anthraquinone
9,10-Phenanthraquinone
Aloe-emodin
Chrysophanol
Emodin
Terpenes
Asiatic acid Primary Sprague–Dawley rat
cortical neurons
10 µM Patil et al.
(2010)
Bilobalide Th-T assay 14.84%b Xie et al.
(2014)
Carnosic acid U373MG human astrocytoma
cells
50 µM Yoshida
et al.
(2014)
Ginkgolide A Th-T assay 21.10%b Xie et al.
(2014)
Ginkgolide B Th-T assay 13.56%b Xie et al.
(2014)
Unilamellar vesicles,
Ab42-induced liposome
permeabilization
50 µM Gauci et al.
(2011)
Ginkgolide C Th-T assay 13.92%b Xie et al.
(2014)
Hyperforin Hippocampal neuron
cultures-amyloid ﬁbrils and
Ab oligomer-induced damage
1 µM Dinamarca
et al.
(2006)
(continued)
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human SH-SY5Y neuroblastoma cells (with menadione as oxidative stress inducer).
In the same line, myricetin also evidenced a similar potential, being together with
quercetin the flavonols with the highest in vitro potential.
Two phenolic acids (ferulic acid and p-coumaric acid) and the flavonol
(kaempferol) also showed interesting effects, directly related to their potent
antioxidant activity. The active concentrations were 1.563–12.5 lM (ferulic acid),
5, 25, 50 lM (p-coumaric acid), and 3–30 lM (kaempferol). Other phenolic acids,
such as rosmarinic (23.6 lM) and 3,5-di-caffeoylquinic (20 lM) acids, also evi-
denced signiﬁcant effects, followed by the flavan-3-ols (catechin, EGCG, and
epicatechin) and the flavones (apigenin, baicalein, and luteolin), which were
effective at 30 lM. On the other hand, the flavones (morin and scutellarein), the
flavonol ﬁsetin, the isoflavone genistein, the lignan NDGA, and, lastly, the stilbene
resveratrol were only effective at 50 lM. Finally, caffeic and chlorogenic acids
proved to be the least effective, once the active concentrations were 118 lM and
2000 lM, respectively, which correspond to the IC50 values.
By comparing the in vitro neuroprotective effects of phenolic compounds with
other bioactive non-phenolic compounds (Table 2), it is clearly evident that the ﬁrst
ones evidenced a greater effect, mainly the flavonols (quercetin and myricetin),
being highly effective at lower doses. It is particularly convenient to highlight the
effect of the following terpenes: hyperforin (1 lM), ursolic acid (1, 10, 20 lM), and
asiatic acid (10 lM) which presented the most prominent activity at lower con-
centrations. Salidroside, a glycoside, several quinones (1,4-benzoquinone,
1,4-naphthoquinone, 9,10-anthraquinone, 9,10-phenanthraquinone, aloe-emodin,
chrysophanol, and emodin), the terpenes (carnosic acid and ginkgolide B), and
lastly purpurogallin trimethyl ether and rhein evidenced similar effects to those of
phenolic compounds, which were effective at 50 lM.
Overall, the phenolic compounds seem to present more signiﬁcant in vitro neu-
roprotective effects than non-phenolic molecules, which might be attributed to their
Table 2 (continued)
Bioactive molecule Experimental models Active
concentration
Reference
Ursolic acid PC12 cells, Ab25−35-induced
toxicity
1, 10, 20 µM Yoon et al.
(2014)
Withanolide A Primary Sprague–Dawley rat
cortical neurons
100 µM Patil et al.
(2010)
Others
Purpurogallin trimethyl
ether
Unilamellar vesicles,
Ab42-induced liposome
permeabilization
50 µM Gauci et al.
(2011)
Rhein Insulin as amyloid model 50 µM Gong et al.
(2014)
aIC50 values;
binhibition percentage of the tested compounds at the concentration of 100 µM
Th-T assay and Thioflavin-T assay
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higher antioxidant potential, namely as free radical scavengers and also as metal
quenchers and hydrogen donators (Heim et al. 2002; Grotewold 2006; Li et al. 2014).
4.1.2 Plant-Food-Derived Molecules
Tables 3, 4 and 5 show the in vitro neuroprotective effects of plant-origin phenolic
and non-phenolic molecules.
In relation to phenolic compounds (Table 3), isoflavones, such as 5,7,4′-
tryhydroxy-6,3′-diprenyllisoflavone (4.47 lM) and osajin (5.01 lM) obtained from
Flemingia macrophylla L., gave the most promissory effects, followed by the lig-
nan, olivil-4′-O-b-D-glucopyranoside (5; 12.5; 25 lM) and (+) pinoresinol-4-4′-di-
O-b-D-glucopyranoside (5; 12; 25 lM), both obtained from Valeriana amurensis
P. Smirn. ex. Kom., and, lastly, the phenolic acid, rosmarinic acid (5; 15; 25 lM),
from Rosmarinus ofﬁcinalis L.
Despite the scarce results on in vitro neuroprotective effects of non-phenolic
compounds (Table 4), when compared with the ﬁrst ones, they evidence a higher
Table 6 Bioactive compounds (from commercial origin) with reported in vivo
Bioactive
molecule
Experimental models Active
concentration
Reference
Flavones
Luteolin Male Sprague–Dawley rat model of
chronic cerebral hypoperfusion
50, 100,
200 mg/kg b.
w.
Fu et al.
(2014)
Flavonols
Quercetin Wild-type adult zebra ﬁsh
scopolamine-induced amnesia
50 mg/kg b.w. Richetti et al.
(2011)Rutin 50 mg/kg b.w.
Hydroxycinnamic acids
3,5-di-O-
Caffeoylquinic
acid
Male SAMP8 and SAMR1 mice 6.7 mg/kg b.
w.
Han et al.
(2010)
Ferulic acid Transgenic PSAPP mouse model of
cerebral amyloidosis
30 mg/kg b.w. Mori et al.
(2013)
Isoflavones
Genistein Male Wistar rats injected with Ab1–40 10 mg/kg b.w. Bagheri et al.
(2012)
Terpenes
Hyperforin Male Sprague–Dawley rats injected with
amyloid ﬁbrils
6 µM Dinamarca
et al. (2006)
Phenylpropanoids
6-Shogaol Male ICR mice AbO1-42-induced
microglial cell activation
10 mg/kg b.w. Moon et al.
(2014)
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and more promissory effect. Coumarins obtained from the rhizomes of
Eleutherococcus senticosus (Rupr. Et Maxim.) Maxim., namely isofraxidin and
isofraxidin 7-O-glucoside, and also saponins, which include stigmasterol 3-O-b-D-
glucopyranoside and eleutheroside E and B, exert a higher effect than phenolic
compounds. Its active concentrations were for both coumarins and saponins, 1 and
10 lM.
Several terpenes, such as spirafolide (5.7 lM) from the leaves of Laurus nobilis
L., and others obtained from the rhizomes and roots of Valeriana amurensis were
also effective at lower concentrations (5; 12; 25 lM), being able to reduce apoptosis
in human neuroblastoma cells and PC12 cells.
The bioactive constituent, (3R) 1,7-diphenyl-(4E,6E)-4,6-heptadien-3-ol,
obtained from Curcuma comosa Roxb., was highly effective (0.1; 0.5; 1 lM)
(Table 5), being able to reduce lipopolysaccharide (LPS)-induced NO and PGE2
production, in a dose-dependent manner. Furthermore, the active concentrations
Fig. 1 Overview of the in vitro neuroregenerative effects of speciﬁc phytochemicals. Legend:
BDNF brain-derived neurotrophic factor; ERK extracellular signal-regulated kinase; CREB cyclic
AMP response element-binding protein; iNOS inducible nitric oxide synthase. The effects were
observed by using the concentrations 0.1, 0.3, and 1 µM of each one of the tested compounds in
cerebral cells from the cortex of fetal Sprague–Dawley rats (Jeon et al. 2010)
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were also able to reduce inducible NO synthase and cyclooxygenase 2 (COX-2).
Similarly, b-sitosterol 3-O-b-D-glucopyranoside (1; 10 lM) obtained from the
rhizomes of Eleutherococcus senticosus strongly inhibited neuritic atrophy induced
Zingiber purpureum Roscoe 
Cis-3-(3’4’-dimethoxyphenyl)-4-
[(E)-3’’,4’’-
dimethoxystyryl]cyclohex-1-ene
Trans-3-(3’4’-
dimethoxyphenyl)-4-[(E)-
3’’,4’’-
dimethoxystyryl]cyclohex-1-ene
Induce neurite 
sprouting  
(30 µM) 
Increase neurite 
length and number  
(0.3–3 µM) 
Protect against cell 
death  
(3-30 µM) 
Induce neurite 
sprouting 
(10-30 µM) 
Increase neurite 
length and number 
(0.03–3 µM) 
Protect against cell 
death  
(30 µM) 
Fig. 2 In vitro neuroregenerative effects of phenylbutanoid dimers obtained from the methanol
extract of Zingiber purpureum Roscoe. roots. Legend Protection against cell death and induction of
neurite sprouting was assessed by using PC12 cells, while the evaluation of neurite length and
number improvement was carried out in cultured primary cortical neurons of rats (Matsui et al.
2012)
Fig. 3 Bioactive molecules from commercial sources with in vitro neuroregenerative effects.
Legend Effects of flavonoids on the mitochondrial function were assessed by using 1 µM of each
one in murine neuroblastoma N2a cells, and then, measure its activity at a level of ROS
production, MMP and ATP levels (Dragicevic et al. 2011); evaluation of Ab production was
assessed by using 50 µM of each one of the tested compounds in CHO 2B7 cells (Chen et al.
2006)
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by Ab25–35, being clearly evident its protective effects against cognitive and
memory impairments. 2,3-Dihydroxy-4-methoxyacetophenone (10.94 lM), iso-
lated from the roots of Cynanchum paniculatum (Bunge), also evidenced a pro-
nounced effect against neuronal damage and toxicity, in HT22 cells, induced by
glutamate.
Overall, and comparing the efﬁcacy and efﬁciency of the studied bioactive
molecules in relation to its sources (commercial vs. plant origin), it is possible to
conclude that plant-origin bioactive compounds possess a doubtless prominent
potential. Although some of them were not studied and then compared from both
sources, several examples should be highlighted. While for luteolin, derived from
commercial (30 lM) and plant (30, 40, and 50 lM) sources, similar active con-
centrations were found, for rosmarinic acid a completely different situation was
observed; the commercial molecule was effective at 23.5–50 lM, while the one
from plant origin was effective at 5, 15, and 25 lM. Similarly, resveratrol isolated
from Vitis vinifera L. was highly effective at 10 and 20 lM, while the commercial
Fig. 4 Plant-origin bioactive molecules with in vivo neuroregenerative effects. Legend Magnolia
ofﬁcinalis Rhed plant (Matsui et al. 2009) and Zingiber purpureum Roscoe root (Matsui et al.
2012) methanol extracts
Fig. 5 Bioactive molecules (from commercial origin) with in vivo neuroregenerative effects.
1Dragicevic et al. (2011), 2Chen et al. (2006)
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molecule was active at 50 lM. Moreover, carnosic acid obtained from R. ofﬁcinalis
was effective at 10, 20, and 30 lM, while the commercial one was active at 50 lM.
In the same line, the phenylethanoid glycosides, acteoside, and oraposide were also
more effective when derived from natural sources (8.9 and 3.6 lM) in comparison
with the commercial molecules (>200 lM). Finally, salidroside isolated from
Rhodiola sachalinensis A. Bor was effective at 1; 5; 10; 50 lg/Ml, while the
commercial molecules were effective at 3; 15; 30 lg/mL.
In summary, plant-food-derived bioactive molecules appear to be more effective
than the commercial ones; notwithstanding, further studies are necessary to conﬁrm
this. Besides, the conﬁrmation of the effective neuroprotective potential needs to be
performed, mainly by in vivo studies, once numerous biochemical parameters
influence the ﬁnal bioactivity and active concentrations.
4.2 Bioactive Compounds with In Vivo Neuroprotective
Activity
Tables 6 and 7 show, respectively, bioactive molecules from commercial and
plant origins with reported in vivo neuroprotective effects. Comparing with the
previously discussed in vitro neuroprotective effects, only commercial quercetin,
ferulic acid, genistein, and hyperforin and bisdemethoxycurcumin, curcumin,
demethoxycurcumin, 1,2,3,4,6-penta-O-galloyl-b-D-glucopyranose, and 2,3-dihydroxy-
4-methoxyacetophenone from plant food origin were also evaluated. Higher concen-
trations were necessary to obtain the same effect on in vivo experiments. For example,
hyperforin at 1 lM was effective under an in vitro model, while 6 lM was the active
concentration in the in vivo experiment. Additionally, when compared with the in vitro
reports, in vivo studies are signiﬁcantly scarce. But despite this limitation, the obtained
achievements need to be highlighted in order to systematize the knowledge on this area.
Phenolic compounds seem to be the most studied phytochemicals regarding
neurocognitive beneﬁts. The effects of flavonols have been evaluated using both
commercial and plant-origin molecules; flavones, hydroxycinnamic acids, and
isoflavones were only studied in commercial forms, while anthocyanins and tannins
were obtained from natural extracts (Vitis vinifera L. and Paeonia suffruticosa
Andr., respectively). Commercial terpenes and phenylpropanoids, and curcumi-
noids and other plant-origin biomolecules were also investigated for neuroprotec-
tive effects.
Rats and mice, followed by wild-type adult zebra ﬁsh and Drosophila melano-
gaster, including species with induced genetic variations, have been themost frequent
animal models used. According to the selected animal model, several active con-
centrations for each bioactive molecule have been observed. Moreover, none of the
studied bioactive molecules were evaluated from both commercial and plant-origin
sources, being difﬁcult to make comparisons of their effectiveness/efﬁciency.
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Among the tested commercial flavones, luteolin showed a dose-dependent effect,
mainly acting as downregulator of NF-Kb and BACE-1, and decreased Ab depo-
sition (Fu et al. 2014). On the other hand, by using a standard concentration of
50 mg/kg b.w., Richetti et al. (2011) observed that both flavonols, quercetin and
rutin, were able to prevent memory and cognitive impairments. Similarly, Mori et al.
(2013) observed that ferulic acid (30 mg/kg b.w.) reversed transgene-associated
behavioral deﬁcits and decreased brain parenchymal and cerebral vascular
b-amyloid deposits and also hyperforin at 6 µM (Dinamarca et al. 2006).
Moon et al. (2014) proved that the phenylpropanoid, 6-shogaol, at 10 mg/kg b.w.
was effective in reducing microgliosis and astrogliosis, ameliorating AbO1-42-
induced memory impairment and elevating NGF levels, and also pre- and postsy-
naptic markers. In the same line, Bagheri et al. (2012) observed that genistein at the
same concentration (10 mg/kg b.w.) leads to a signiﬁcant inhibition of neurode-
generation and Ab1-40-positive aggregate formation, alleviating consequently
extensive astrogliosis. The hydroxycinnamic acid, 3,5-di-caffeoylquinic acid
(6.7 mg/kg b.w.), also showed a pronounced effect, being able to decrease in a
signiﬁcant manner escape latency time, by increasing PGK1 and mRNA expression,
and also ATP production (Han et al. 2010).
In relation to plant-origin bioactive molecules, all of them were able to prevent
memory and cognitive impairments, in different proportions. For example, antho-
cyanins from Vitis vinifera L. fruits extract (200 mg/kg b.w.) exerted beneﬁcial
effects mainly by preventing scopolamine-induced neurotoxic effects (Gutierres
et al. 2014), while curcuminoids (bisdemethoxycurcumin, curcumin, and
demethoxycurcumin) from Curcuma longa L. rhizomes extract, at the concentration
of 1 mM, rescued morphological defects on Drosophila melanogaster improving
the movement coordination (Wang et al. 2014b). In a similar manner, kaempferol
(12 and 24 ppm), 1,2,3,4,6-penta-O-galloyl-b-D-glucopyranose (8 mg/kg b.w.), and
2,3-dihydroxy-4-methoxyacetophenone (50 mg/kg b.w.) obtained, respectively,
from Brassica oleraceae var. gemmifera, Paeonia suffruticosa Andr., and
Cynanchum paniculatum (Bunge) Kitag. markedly reduced escape latency time: the
ﬁrst one by its contribution on the reduction in ROS production and consequently
improvement in step-through latency time (Kim et al. 2013), the second one
through the inhibition of Ab ﬁbril formation as also destabilization of the preformed
Ab ﬁbrils (Fujiwara et al. 2009), and the last one, related to NMDA receptor
inhibition and breakdown of AChE (Weon et al. 2013).
The above-described neuroprotective beneﬁts, both in vivo and in vitro, incite
the future use of bioactive molecules from plant food origin as leaders to the AD
treatment. It is also important to highlight that despite its neuroprotective and
preventive effects, and even treatment/alleviation of the symptomatic conditions,
these phytochemicals also possess an interesting and underexplored neuroregen-
erative potential, which needs to be studied in detail.
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5 Plant Food Bioactive Molecules with Neuroregenerative
Activity
5.1 Bioactive Compounds with In Vitro Neuroregenerative
Activity
In addition to the previously stated promissory neuroprotective beneﬁts of plant
food bioactive constituents, its neuroregenerative effects have also been studied, but
still have a low progression. Figures 1 and 2 show plant-origin bioactive molecules
with prominent in vitro neuroregenerative potential, while Fig. 3 shows results of
commercial molecules. Once again, is clearly evident the scarcity of the studied
plant species: Cinnamomum cassia Blume, Coptis chinensis Franch., Pueraria
montana (Lour.) Merr. var. lobata (Willd.) Maesen & Almeida, Salvia miltiorrhiza
Bunge and Scutelaria baicalensis Georgi (Fig. 1), and Zingiber purpureum Roscoe.
Figure 2 shows the currently recognized sources of bioactive molecules with
in vitro neurodegenerative beneﬁts. In particular, baicalein, cinnamic acid,
epiberberine, genistein, tanshinone IIA, and wogonin, at low concentrations (0.1,
0.3, and 1 µM), evidenced to act synergistically on the brain-derived neurotrophic
factor (BDNF) release, mRNA, and protein expression, mainly by phosphorylation
of extracellular signal-regulated kinase (ERK) and cyclic AMP element-binding
protein (CREB), and inhibition of inducible nitric oxide synthase (iNOS) upregu-
lation. Jeon et al. (2010) clariﬁed those effects by using cortex cerebral cells from
fetal Sprague–Dawley rats. On the other hand, Matsui et al. (2012) by using PC12
cells observed that both isolated phenylbutanoid dimers from Z. purpureum (Fig. 2)
were able not only to induce neurite sprouting (10–30 µM), but also to confer a
signiﬁcant protection against cell death (3–30 µM). Furthermore, the authors
observed a pronounced induction of the number and length of neurites (0.03–3 µM)
by using primary cortical neurons of rats.
Apart from the studied plant food molecules, several commercial biomolecules
were also investigated, mainly in what concerns to the ability to restore mito-
chondrial functions and reduce Ab production (Fig. 3). In general, phenolic com-
pounds were the most frequently studied biomolecules toward to assess
mitochondrial function restauration ability, while saponins have been studied to
determine the effect on Ab production. Indeed, and as previously mentioned,
phenolic compounds are widely recognized for their antioxidant potential (mainly
as free radical scavengers, metal quenchers, and hydrogen donators) (Heim et al.
2002; Grotewold 2006; Li et al. 2014). Commonly known as “powerhouse of the
cells,” “ATP reservoir” or “energetic factory,” mitochondria contribute not only to
the proper cellular function, but also to an intensive free radical production (one of
the most important endogenous sources of ROS). In fact, brain cells need a higher
and continuous demand for energy supply (Chaturvedi and Beal 2013). Therefore,
it is of the utmost importance not only to ensure a proper neuronal function, but also
to avoid cellular damages, by discovering new and effective alternatives to restore
the optimum mitochondrial functions (in case of injuries). Taking into account
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those features, several biomolecules have been intensively investigated. It should be
pointed that, by itself, a free radical overproduction is not only a triggering factor to
AD development, but also promotes Ab production, which leads to an intense
organic dysfunction and inflammation. As shown in Fig. 3, flavanones (hesperitin,
naringenin), flavan-3-ols (catechin, EGCG), flavones (acacetin, aminoflavone,
apigenin, baicalein, chrysin, diosmetin, diosmin, luteolin, methoxyflavone, and
methylflavone), flavonols (quercetin), and phenolic acids (ferulic acid, methyl
cinnamate, and methyl gallate) are among the most prominent phenolic compounds
with mitochondrial function restauration ability, at the concentration of 1 µM, in
murine neuroblastoma N2a cells. To evaluate the potential of those molecules,
Dragicevic et al. (2011) used the levels of ROS, MMP, and ATP as positive
indicators.
On the other hand, Chen et al. (2006) observed that saponins, at the ﬁnal con-
centration of 50 µM, exerted considerable effects on Ab40 (ginsenoide Rb1,
panaxadiol) and Ab42 (ginsenoide Rg1, pseudoginsenoside F11) and also on Ab40
and Ab42 (ginsenoide Rb2, Re, Rg3; notoginsenoside R1) reduction, by using
CHO 2B7 cells. In spite of the great interest of these results, further studies are
necessary to assess the in vivo effects, including security (mainly to saponins,
which depending to the used doses, are often slightly toxic) and bioavailability, and
also to establish the therapeutic doses.
5.2 Bioactive Compounds with In Vivo Neuroregenerative
Activity
Figures 4 and 5 show the in vivo neuroregenerative effects of bioactive molecules
from plant and commercial origins, respectively. Among the bioactive molecules
from plant origin, only individual phytochemicals obtained from Magnolia ofﬁci-
nalis Rhed and Zingiber purpureum Roscoe were evaluated (Fig. 4). M. ofﬁcinalis
lignans presented the better effect, namely honokiol (1 mg/kg b.w.) and magnolol
(10 mg/kg b.w.) (Matsui et al. 2009), on the prevention of learning and memory
impairments, age-related cholinergic deﬁcits, as also on the improvement in Akt
phosphorylation in SAM8 mice forebrain. The phenylbutanoid dimers (50 mg/kg b.w.)
appear as the great contributors to OBX mice BrdU/NeuN double-labeled cell
improvement (Matsui et al. 2012). In general, the authors concluded that the
mentioned phytochemicals possess promissory neurotrophic effects; so, their further
investigation is of the utmost importance, to be effectively used, in the near future,
to threat and even to modify the course of several neurological disorders.
Among the commercial bioactive compounds (Fig. 5), the flavan-3-ols with a
renowned and doubtless antioxidant potential, namely EGCG (37.1 mg/kg b.w.) from
green tea (Dragicevic et al. 2011), were the most studied, and also triterpenoid
saponins that include ginsenosideRe,Rg1, andRg3 (25 mg/kg b.w.) (Chen et al. 2006).
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In the ﬁrst case, EGCG was able to improve the activity of a-secretase and to reduce
brain mitochondrial Ab and AbPP levels in AbPP/PS1 double-mutant transgenic
mouse models. Otherwise, ginsenoside Re, Rg1, and Rg3 evidenced a higher potential
to reduce not only Ab42, but also Ab40 brain levels in Tg2576 female transgenic mice
models that overexpress the human APP gene.
Overall, and despite the described effects of the tested bioactive components, it is
difﬁcult to compare their efﬁcacy and also efﬁciency once different biochemical
parameters were assessed, and also biological antineuronal damage effects.
6 Neuromodulation and Neuroplasticity: Future Trends
to an Optimum Brain Health
The in vitro and in vivo promissory neurocognitive beneﬁts evidenced by plant
products clearly point to an upcoming approach as future leaders on neurodegen-
erative diseases. In particular, their neuroprotective effects are pivotal once pre-
vention comprises one of the most important key points on integrative intervention.
Notwithstanding, in some cases, considerable changes on learning and memory
abilities, and also lagged perceptions and neuronal losses, are found, which requires
a therapeutic intervention (van Praag 2009; Essa et al. 2012; Yoo and Park 2012;
Ahmed et al. 2015).
Otherwise, along with the disseminated idea that brain cells (such as neurons,
microglia, and other glial cells) are not able to regenerate, increasing evidences
have shown that they possess an interesting ability to synapse remodeling and
consequently to recover its synaptic plasticity, neuronal spine density, and, there-
fore, cognitive improvement. Numerous signaling molecules, transporters, and
codifying proteins, genes, and so on are involved on the mentioned complex pro-
cess (McCoy et al. 2009; van Praag 2009; Nadim and Bucher 2014; Wester and
McBain 2014). Plant-derived bioactive molecules, and also physical exercise, have
shown to act as important contributors, once rest neurodegeneration, and improve
neuroregenerative processes (van Praag 2009). In spite of their pivotal biological
interests, the neuromodulatory and neuroplasticity abilities of numerous bioactive
molecules remain poorly investigated, as also the involved modes of action. For
example, it is convenient to highlight that 2,3,5,4′-tetrahydroxystilbene-2-O-b-D-
glucoside (TSG), a phenolic compound derived from Polygonum multiflorum
Thunb., evidenced potent cognitive improving and hippocampal synaptic plasticity
promoting (Wang et al. 2011) abilities: facilitates the induction of hippocampal
long-term potentiation (LTP) through activation of postsynaptic signal molecules
and other signalling pathways, which contributes to the in vivo improvement of
learning behavior, memory, and neuronal networks in rats. Liang et al. (2014) also
showed that dihydromyricetin (DHM), a flavonoid compound, restores gephyrin (a
postsynaptic anchor protein at GABAergic synaptic sites) levels, when adminis-
tered in mouse models with AD. Gephyrin is directly involved on GABA receptor
292 N. Martins and I.C.F.R. Ferreira
functioning, once regulates its formation, plasticity and availability, as also from
other signalling molecules (Liang et al. 2014). Furthermore, Zhan et al. (2014)
observed that berberine, a plant alkaloid, was able to reverse synaptic deﬁcits
induced by D-galactose and rescued important intermediates (mRNA, Arc/Arg3.1)
directly involved on normal synaptic plasticity.
Otherwise, and in association with the previous stated effects, it is also important
to point out that hypothalamic neuromodulator systems are also affected/affect daily
energy homeostasis. For example, under speciﬁc conditions (such as short-term
fasting and other metabolic state changes), considerable synaptic circuits and
respective (inter)neuronal controllers suffer from restructuration, which leads to
physiological variations on energy homeostasis and may cause synaptic plasticity
impairments (Horvath 2006). Thus, the above-described mechanisms of action of
bioactive molecules can be also extremely useful in other contexts, such as feeding
and appetite controllers. For example, plant-derived cannabinoids (phytocannabi-
noids) and endocannabinoids, in spite of the whole negative connotation attributed
to cannabis, have shown greater contributive properties not only for physiological
appetite and satiety controllers (Berry and Mechoulam 2002), but also for brain
therapeutical purposes (i.e., neuromodulators, neuroprotective, neuroregenerative,
and synapsis plasticity regulators) (Fisar 2009).
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